Difficulties for recruitment

This study compares the apparition of hypoglycaemia in type I diabetic patients between 2 phases: the one without the use of SmartGuard® function and the one with the use of SmartGuard® function.

The aim of this study is to compare SmartGuard® function with captor and insulin pump to improve the glycemia stability in real condition.

There are several phases:

• phase 1: insulin pump without captor (12 weeks)
• phase 2: insulin pump with captor and without SmartGuard® function (4X6 days; 4 weeks)
• phase 3: insulin pump with captor and with SmartGuard® function (6X6 days; 6 weeks)
• phase 4: insulin pump without captor (4 weeks)

Inclusion Criteria:

• type I diabetic patients undr basal/prandial diet
• treated by insuline
• with no insuline pump during at least 3 months
• with HbA1C dosed during the 3 months before inclusion

Exclusion Criteria:

• minor patients
• pregnant woman
• already participating to another studies